CC BY 4.0 · J Neuroanaesth Crit Care 2023; 10(01): 072-074
DOI: 10.1055/s-0043-1763263
Correspondence

Phenytoin-Induced Red Discoloration of Urine in a Pediatric Neurosurgical Patient: An Unusual Finding

Sakshi Kadian
1   Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
,
Siddharth Chakraborty
1   Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
,
1   Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
,
Sanjay Agrawal
1   Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
› Author Affiliations
 

The use of phenytoin is widespread in neurosurgical patients, especially in space-occupying lesions. It has predominant renal excretion and has been known to cause tubulointerstitial nephritis on chronic use. Despite its common use, there has not been definitive literature on urine discoloration due to phenytoin except for a commentary dated back in 1983 which refuted the finding of urine discoloration by phenytoin use.[1] Hence, we intend to highlight a case where there was episode of red discoloration of urine in a pediatric patient posted for excision of the cerebellar tumor under general anesthesia.

A 9-year-old female, weighing 30 kg, presented to the neurosurgical department with complaints of headache and vomiting for 1 month. On examination, her Glasgow Coma Scale was E4V5M6 with no neurological deficit, left side cerebellar signs were positive, including dysdiadokinesia and finger nose test. Contrast-enhanced magnetic resonance imaging revealed a 3 × 3.5 × 4 cm lesion in the left cerebellar hemisphere with mild hydrocephalus ([Fig. 1]). She was started on tablet levetiracetam 300 mg twice daily, syrup glycerol three tablespoons four times a day, and tablet acetazolamide 250 mg twice daily. She was posted for tumor resection by mid-line suboccipital craniotomy in the prone position. The blood investigations were within normal limits on the day of surgery; after confirming the nil per oral status, the patient was wheeled into the operating room. All the standard monitors, as per ASA (American Society of Anesthesiologists) recommendations, were attached. General anesthesia was induced as per the institute protocol. The patient was positioned prone, and surgery was started. The tumor excision was done. After the hemostasis was achieved, the neurosurgeon advised giving the loading dose of phenytoin given hydrocephalus. As per the advice, 450 mg phenytoin was put in 100 mL of 0.9% normal saline and infusion was started. After about 5 minutes, we noticed hypotension, which responded to a bolus of intravenous crystalloid administration. After about 10 minutes, we observed red discoloration of urine in the urinary catheter tubing ([Fig. 2]). Since phenytoin was the only additional drug administered in temporal association, it was stopped immediately. About 200 mL of 0.9% normal saline was given. After about 15 minutes, again, the color of the urine normalized. There was no similar episode of urine discoloration further. The patient was extubated and shifted to the neurosurgical intensive care unit.

Zoom Image
Fig. 1 T1 sagittal magnetic resonance imaging (MRI) scan showing left cerebellar space-occupying lesion (arrow).
Zoom Image
Fig. 2 Red color of the urine in urinary catheter tubing, which occurred in temporal association with the administration of phenytoin.

Drug reaction with eosinophilia and systemic symptom (DRESS) syndrome, including a severe skin eruption, fever, hematologic abnormalities (eosinophilia or atypical lymphocytes), and internal organ involvement, usually 2 to 6 weeks after the initiation of drug therapy is a severe adverse drug reaction.[2] The anticonvulsants, including phenytoin and sulfonamide drugs, are most commonly associated with DRESS. The use of antiepileptic drugs (phenytoin, valproic acid, carbamazepine) has also been associated with tubulointerstitial nephritis.[3] Park et al reported a case of acute glomerulonephritis and drug-induced antineutrophil cytoplasmic antibody-associated vasculitis in a 65-year-old male patient with phenytoin use.[4]

But this usually occurs after around 1 month of phenytoin use. However, the association of phenytoin with urine discoloration has not been aptly studied. There was a finding written in text of urology in 1978 stating that in the presence of urinary acid pH, phenytoin can result in red urine.[5] Derby and Ward did a detailed investigation on that urology text and followed all the sources from which this finding was reported.[1] On investigating Parke-Davis product information they did not find any reliable source of such finding. They found out some references where pink, red, and brown discoloration of urine were listed owing to phenytoin use.[6] [7] [8] They continued their investigation to trace the source and found out that the source of reference was from a medical text by Shirkey.[9] They contacted him and were surprised to find out that he did not have any knowledge of such finding been mentioned. Based on their extensive investigation, they refuted the finding of urine discoloration by phenytoin. With this case report, we intend to mention the fact that phenytoin can cause red discoloration of urine as evidenced by us and this could occur even in the presence of alkaline urine as the patient in our case was on acetazolamide. Hence, we conclude that whenever there is such adverse reaction in the presence of phenytoin, the causal relationship can be attributed to the drug. Further detailed studies are warranted to know the exact pathophysiology behind this finding.


#

Conflict of Interest

None declared.

  • References

  • 1 Derby BM, Ward JW. The myth of red urine due to phenytoin. JAMA 1983; 249 (13) 1723-1724
  • 2 Criado PR, Criado RF, Avancini JM, Santi CG. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. An Bras Dermatol 2012; 87 (03) 435-449
  • 3 Decloedt E, Maartens G. Drug-induced kidney disease. CME 2011; 29: 252-255
  • 4 Park KS, Lee S, Kie JH, Kang EW. A case report of phenytoin-induced anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis. Arch Clin Med Case Rep 2020; 4: 356-361
  • 5 Stecker JF. Examination of the urine. In: Devine CJ, Stecker JF, eds. Urology in Practice. Vol. 95, Chapter 9. Boston: Little Brown & Co; 1978
  • 6 Wade A. ed. The Extra Pharmacopoeia. 27th ed. London: Pharmaceutical Press; 1977: 1227
  • 7 Baran RB, Rowles B. Factors affecting coloration of urine and feces. J Am Pharm Assoc 1973; 13 (03) 139-142
  • 8 Block LH, Lamy PP. These drugs discolor the feces or urine. Am Prof Pharm 1968; 34: 27-29
  • 9 Shirkey HC. Pediatric Therapy. 2nd ed. St Louis, CV: Mosby Co; 1966;56

Address for correspondence

Sanjay Agrawal, MBBS, MD, PDCC
Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences
Rishikesh, Uttarakhand 249203
India   

Publication History

Article published online:
24 April 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Derby BM, Ward JW. The myth of red urine due to phenytoin. JAMA 1983; 249 (13) 1723-1724
  • 2 Criado PR, Criado RF, Avancini JM, Santi CG. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. An Bras Dermatol 2012; 87 (03) 435-449
  • 3 Decloedt E, Maartens G. Drug-induced kidney disease. CME 2011; 29: 252-255
  • 4 Park KS, Lee S, Kie JH, Kang EW. A case report of phenytoin-induced anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis. Arch Clin Med Case Rep 2020; 4: 356-361
  • 5 Stecker JF. Examination of the urine. In: Devine CJ, Stecker JF, eds. Urology in Practice. Vol. 95, Chapter 9. Boston: Little Brown & Co; 1978
  • 6 Wade A. ed. The Extra Pharmacopoeia. 27th ed. London: Pharmaceutical Press; 1977: 1227
  • 7 Baran RB, Rowles B. Factors affecting coloration of urine and feces. J Am Pharm Assoc 1973; 13 (03) 139-142
  • 8 Block LH, Lamy PP. These drugs discolor the feces or urine. Am Prof Pharm 1968; 34: 27-29
  • 9 Shirkey HC. Pediatric Therapy. 2nd ed. St Louis, CV: Mosby Co; 1966;56

Zoom Image
Fig. 1 T1 sagittal magnetic resonance imaging (MRI) scan showing left cerebellar space-occupying lesion (arrow).
Zoom Image
Fig. 2 Red color of the urine in urinary catheter tubing, which occurred in temporal association with the administration of phenytoin.